Evaluating the efficacy of enzalutamide and the development of resistance in a preclinical mouse model of type-I endometrial carcinoma

Christopher S. Koivisto; Melodie Parrish; Santosh B. Bonala; Soo Ngoi; Adrian Torres; James Gallagher; Rebekah Sanchez-Hodge; Victor Zeinner; Georges J. Nahhas; Bei Liu; David E. Cohn; Floor J. Backes; Paul J. Goodfellow; Helen M. Chamberlin; Gustavo Leone

doi:10.1016/j.neo.2020.07.003

Evaluating the efficacy of enzalutamide and the development of resistance in a preclinical mouse model of type-I endometrial carcinoma

Christopher S. Koivisto, Melodie Parrish, Santosh B. Bonala, Soo Ngoi, Adrian Torres, James Gallagher, Rebekah Sanchez-Hodge, Victor Zeinner, Georges J. Nahhas, Bei Liu, David E. Cohn, Floor J. Backes, Paul J. Goodfellow, Helen M. Chamberlin, Gustavo Leone

Research output: Contribution to journal › Article › peer-review

Original language	English
Pages (from-to)	484-496
Number of pages	13
Journal	Neoplasia (United States)
Volume	22
Issue number	10
DOIs	https://doi.org/10.1016/j.neo.2020.07.003
State	Published - Oct 2020
Externally published	Yes

ASJC Scopus Subject Areas

Cancer Research

Keywords

Androgen receptor antagonist
Endometrial carcinoma
Enzalutamide
Mouse model of endometrial cancer
PTEN
Preclinical drug evaluation

Access to Document

10.1016/j.neo.2020.07.003

Cite this

Koivisto, C. S., Parrish, M., Bonala, S. B., Ngoi, S., Torres, A., Gallagher, J., Sanchez-Hodge, R., Zeinner, V., Nahhas, G. J., Liu, B., Cohn, D. E., Backes, F. J., Goodfellow, P. J., Chamberlin, H. M., & Leone, G. (2020). Evaluating the efficacy of enzalutamide and the development of resistance in a preclinical mouse model of type-I endometrial carcinoma. Neoplasia (United States), 22(10), 484-496. https://doi.org/10.1016/j.neo.2020.07.003

Koivisto, CS, Parrish, M, Bonala, SB, Ngoi, S, Torres, A, Gallagher, J, Sanchez-Hodge, R, Zeinner, V, Nahhas, GJ, Liu, B, Cohn, DE, Backes, FJ, Goodfellow, PJ, Chamberlin, HM & Leone, G 2020, 'Evaluating the efficacy of enzalutamide and the development of resistance in a preclinical mouse model of type-I endometrial carcinoma', Neoplasia (United States), vol. 22, no. 10, pp. 484-496. https://doi.org/10.1016/j.neo.2020.07.003

@article{2d925703f4934fcbadbda861933dfe07,

title = "Evaluating the efficacy of enzalutamide and the development of resistance in a preclinical mouse model of type-I endometrial carcinoma",

keywords = "Androgen receptor antagonist, Endometrial carcinoma, Enzalutamide, Mouse model of endometrial cancer, PTEN, Preclinical drug evaluation",

author = "Koivisto, \{Christopher S.\} and Melodie Parrish and Bonala, \{Santosh B.\} and Soo Ngoi and Adrian Torres and James Gallagher and Rebekah Sanchez-Hodge and Victor Zeinner and Nahhas, \{Georges J.\} and Bei Liu and Cohn, \{David E.\} and Backes, \{Floor J.\} and Goodfellow, \{Paul J.\} and Chamberlin, \{Helen M.\} and Gustavo Leone",

note = "Publisher Copyright: {\textcopyright} 2020",

year = "2020",

month = oct,

doi = "10.1016/j.neo.2020.07.003",

language = "English",

volume = "22",

pages = "484--496",

journal = "Neoplasia (United States)",

issn = "1522-8002",

number = "10",

}

TY - JOUR

T1 - Evaluating the efficacy of enzalutamide and the development of resistance in a preclinical mouse model of type-I endometrial carcinoma

AU - Koivisto, Christopher S.

AU - Parrish, Melodie

AU - Bonala, Santosh B.

AU - Ngoi, Soo

AU - Torres, Adrian

AU - Gallagher, James

AU - Sanchez-Hodge, Rebekah

AU - Zeinner, Victor

AU - Nahhas, Georges J.

AU - Liu, Bei

AU - Cohn, David E.

AU - Backes, Floor J.

AU - Goodfellow, Paul J.

AU - Chamberlin, Helen M.

AU - Leone, Gustavo

PY - 2020/10

Y1 - 2020/10

KW - Androgen receptor antagonist

KW - Endometrial carcinoma

KW - Enzalutamide

KW - Mouse model of endometrial cancer

KW - PTEN

KW - Preclinical drug evaluation

UR - https://www.scopus.com/pages/publications/85089427396

UR - https://www.scopus.com/inward/citedby.url?scp=85089427396&partnerID=8YFLogxK

U2 - 10.1016/j.neo.2020.07.003

DO - 10.1016/j.neo.2020.07.003

M3 - Article

C2 - 32818842

AN - SCOPUS:85089427396

SN - 1522-8002

VL - 22

SP - 484

EP - 496

JO - Neoplasia (United States)

JF - Neoplasia (United States)

IS - 10

ER -

Evaluating the efficacy of enzalutamide and the development of resistance in a preclinical mouse model of type-I endometrial carcinoma

ASJC Scopus Subject Areas

Keywords

Access to Document

Other files and links

Cite this